Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01260259 · ClinicalTrials.gov registry record · NA
Seattle Cardiorenal Remote Ischemic Preconditioning Trial
A NA study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01260259 is a NA study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 90 participants.
The verdict
NCT01260259, a NA study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
Remote Ischemic Preconditioning (RIPC) is a treatment that may be associated with improved outcomes after cardiac surgery. It can be elicited noninvasively by using a tourniquet to elicit transient ischemia over a lower extremity. It is thought to promote anti-inflammatory and cell survival pathways, and thus protect remote organs against future ischemic injury. We hypothesize that compared to sham treatment, RIPC will be associated with decreased post-operative acute kidney, myocardial, and lung injury.
Interventions
- PROCEDURE Control
- PROCEDURE RIPC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2010-12 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01260259
The ClinicalTrials.gov registry entry for NCT01260259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT01260259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01260259 about?
NCT01260259 is a clinical study titled "Seattle Cardiorenal Remote Ischemic Preconditioning Trial". Remote Ischemic Preconditioning (RIPC) is a treatment that may be associated with improved outcomes after cardiac surgery. It can be elicited noninvasively by using a tourniquet to elicit transient ischemia over a lower extremity. It is thought to promote anti-inflammatory and cell survival pathways...
What is the current status of trial NCT01260259?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2010-12. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01260259?
The interventions under investigation include: Control (PROCEDURE), RIPC (PROCEDURE).
Who is sponsoring clinical trial NCT01260259?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.